Jim Cramer is still off, but he's eager to come back and will be making his return as soon as possible. Here to fill his shoes is Jeff Marks, senior portfolio analyst.
In intraday trading, the major indices were all lower as investors fret about the Johnson & Johnson (JNJ) - Get Report announcement that its single-shot coronavirus vaccine was 66% effective in a large, late-stage trial. The stock fell 3.82%.
And Novovax said a Phase 3 trial of its Covid-19 vaccine candidate showed 89.3% efficacy against the disease, including against the fast-spreading U.K. variant, but was found to be less effective against the South African variant.
Joining TheStreet Live ahead of Friday's steeper intraday losses, Jeff Marks, senior analyst for Jim Cramer's Action Alerts PLUS portfolio said investors should keep strong earnings reports in mind as attention increasingly shifts to Reddit-fueled moves in GameStop (GME) - Get Free Report and AMC (AMC) - Get Free Report.
Recap TheStreet Live: Everything Moving the Markets Friday
Curious about what Jim Cramer and his team at Action Alerts PLUS are watching in the markets? Watch Cramer's exclusive members-only Daily Rundown show on Action Alerts PLUS following TheStreet Live.